The value of Rauwolfia serpentina in the hypertensive patient
- 1 November 1954
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 17 (5) , 629-640
- https://doi.org/10.1016/0002-9343(54)90022-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Recent Developments in the Treatment of HypertensionMedical Clinics of North America, 1954
- SYNDROME SIMULATING COLLAGEN DISEASE CAUSED BY HYDRALAZINE (APRESOLINE)JAMA, 1954
- RHEUMATIC AND FEBRILE SYNDROME DURING PROLONGED HYDRALAZINE TREATMENTJAMA, 1954
- Studies on the Control of Hypertension by HyphexCirculation, 1953
- Preliminary observations of Rauwiloid-hexamethonium combined therapy of hypertensionAmerican Heart Journal, 1953
- The Use ofRauwolif serpentinain Hypertensive PatientsNew England Journal of Medicine, 1953
- NEW DRUG THERAPIES IN ARTERIAL HYPERTENSIONAnnals of Internal Medicine, 1952
- Acute Effects of Intravenous Administration of a Preparation ofVeratrum Viridein Patients with Severe Forms of Hypertensive DiseaseNew England Journal of Medicine, 1952
- THE HYPOTENSIVE ACTION OF VERILOID (VERATRUM VIRIDE): A CLINICAL INVESTIGATIONThe Lancet, 1951
- Veratrum Viride and Essential HypertensionNew England Journal of Medicine, 1950